Published in Front Cell Dev Biol on November 12, 2014
Potential of epigenetic therapies in the management of solid tumors. Cancer Manag Res (2015) 0.83
DNA methyltransferase 1 mutations and mitochondrial pathology: is mtDNA methylated? Front Genet (2015) 0.78
Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models. Stem Cells Int (2015) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Generation of germline-competent induced pluripotent stem cells. Nature (2007) 32.77
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature (2007) 28.24
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell (2013) 24.00
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet (2000) 21.52
Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 19.57
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A (1981) 18.96
In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature (2008) 16.21
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (1996) 15.91
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med (2004) 13.55
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell (2005) 12.73
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science (2007) 12.41
Wound repair and regeneration. Nature (2008) 12.30
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature (2003) 12.10
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med (2009) 11.68
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol (2013) 11.58
Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature (2005) 11.23
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol (2007) 9.36
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med (2004) 9.11
A gene hypermethylation profile of human cancer. Cancer Res (2001) 8.93
Perceptions of epigenetics. Nature (2007) 8.43
The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab (2004) 7.96
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature (2011) 7.90
Sheep cloned by nuclear transfer from a cultured cell line. Nature (1996) 7.86
Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet (2012) 7.70
Adipose-derived stem cells for regenerative medicine. Circ Res (2007) 7.68
DNA methylation age of human tissues and cell types. Genome Biol (2013) 7.48
Immunogenicity of induced pluripotent stem cells. Nature (2011) 7.31
Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell (2012) 7.17
The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature (2011) 6.71
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol (2010) 6.55
Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell (2013) 6.35
Human embryonic stem cells derived by somatic cell nuclear transfer. Cell (2013) 5.91
Derivation of novel human ground state naive pluripotent stem cells. Nature (2013) 5.90
Direct conversion of human fibroblasts to multilineage blood progenitors. Nature (2010) 5.35
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science (2013) 4.94
An integrated epigenetic and genetic approach to common human disease. Trends Genet (2004) 4.89
Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol (2001) 4.81
The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol (1962) 4.37
Transplantation of Living Nuclei From Blastula Cells into Enucleated Frogs' Eggs. Proc Natl Acad Sci U S A (1952) 4.32
Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet (2009) 4.28
An operational definition of epigenetics. Genes Dev (2009) 4.26
A guide to genome engineering with programmable nucleases. Nat Rev Genet (2014) 4.15
Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci U S A (2011) 3.93
Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature (2011) 3.56
Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell (2011) 3.32
Lin28 enhances tissue repair by reprogramming cellular metabolism. Cell (2013) 3.08
Nuclear reprogramming in cells. Science (2008) 3.04
Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells (2006) 2.77
Cellular stress responses: cell survival and cell death. Int J Cell Biol (2010) 2.74
Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell (2008) 2.74
Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood (1992) 2.62
Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Nat Rev Drug Discov (2011) 2.58
In vivo reprogramming of astrocytes to neuroblasts in the adult brain. Nat Cell Biol (2013) 2.56
Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature (2013) 2.47
Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell (2013) 2.45
Mapping human epigenomes. Cell (2013) 2.44
The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS One (2007) 2.41
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32
Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell (2013) 2.31
Lamin A/C expression is a marker of mouse and human embryonic stem cell differentiation. Stem Cells (2005) 2.25
Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell (2012) 2.15
Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation (2003) 2.11
Clinical trials for stem cell therapies. BMC Med (2011) 2.06
Spemann's organizer and self-regulation in amphibian embryos. Nat Rev Mol Cell Biol (2006) 2.05
Epigenetics and human disease: translating basic biology into clinical applications. CMAJ (2006) 1.98
Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood (2011) 1.92
Transient inactivation of Rb and ARF yields regenerative cells from postmitotic mammalian muscle. Cell Stem Cell (2010) 1.89
Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency. Cell Rep (2012) 1.84
Wnt proteins promote bone regeneration. Sci Transl Med (2010) 1.80
Chromatin dynamics during cellular reprogramming. Nature (2013) 1.79
Molecular roadblocks for cellular reprogramming. Mol Cell (2012) 1.74
Epigenetics of reprogramming to induced pluripotency. Cell (2013) 1.73
Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev (2011) 1.73
Reprogramming cellular identity for regenerative medicine. Cell (2012) 1.71
Historical origins of transdifferentiation and reprogramming. Cell Stem Cell (2011) 1.69
Stem cell quiescence. Clin Cancer Res (2011) 1.69
Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat Commun (2014) 1.68
Wnt signaling promotes Müller cell proliferation and survival after injury. Invest Ophthalmol Vis Sci (2013) 1.60
MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet (2000) 1.58
Investigating monogenic and complex diseases with pluripotent stem cells. Nat Rev Genet (2011) 1.55
REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. Mol Interv (2002) 1.49
Mitochondrial rejuvenation after induced pluripotency. PLoS One (2010) 1.46
Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev (2010) 1.43
Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res (2011) 1.41
Investigating human disease using stem cell models. Nat Rev Genet (2014) 1.41
Rethinking differentiation: stem cells, regeneration, and plasticity. Cell (2014) 1.41
The genetics and epigenetics of autoimmune diseases. J Autoimmun (2009) 1.40
Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits. Nat Biotechnol (2013) 1.38
Induced pluripotent stem cells in medicine and biology. Development (2013) 1.35
Regeneration, repair and remembering identity: the three Rs of Hox gene expression. Trends Cell Biol (2009) 1.35
Tissue engineering and regenerative medicine: recent innovations and the transition to translation. Tissue Eng Part B Rev (2013) 1.34
Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity. Aging Cell (2013) 1.33
Tissue engineering and regenerative medicine: history, progress, and challenges. Annu Rev Chem Biomol Eng (2011) 1.31
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21. EMBO Mol Med (2013) 1.30
The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev (2004) 1.29
Reprogramming nuclei: insights from cloning, nuclear transfer and heterokaryons. J Cell Sci (2000) 1.28
Epigenetics across the human lifespan. Front Cell Dev Biol (2014) 0.93
Cellular Senescence as the Causal Nexus of Aging. Front Genet (2016) 0.80